<p>Section 1 Diabetes Mellitus </p> <p>1. Definition and Epidemiology of Type 2 Diabetes Mellitus </p> <p>2. Insulin Resistance: Pathophysiology, Molecular Mechanisms, Genetic Insights </p> <p>3. Type 1 Diabetes: Pathophysiology, Molecular Mechanisms, Genetic Insights </p> <p>4. The Metabolic Syndrome: Prevalence and Controversies in Clinical Context</p> <p>5. Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus</p> <p>6. Pharmacologic and Surgical Interventions That Prevent or Worsen Type 2 Diabetes </p> <p>Section 2 Diabetes and Atherosclerosis </p> <p>7. Epidemiology of Coronary and Peripheral Atherosclerosis in Diabetes </p> <p>8. Pathology of Diabetic Atherosclerosis: Composition, Characteristics, and Distribution </p> <p>9. Vascular Biology of Atherosclerosis in Patients with Diabetes: Hyperglycemia, Insulin Resistance, and Hyperinsulinemia</p> <p>10. Vascular Biology of Atherosclerosis in Patients with Diabetes: Inflammation, Dyslipidemia, Hypercoagulability, Endothelial Dysfunction, and Inflammation</p> <p>11. Type 1 Diabetes and Associated Cardiovascular Risk and Disease </p> <p>Section 3 Management of Coronary Heart Disease Risk and Disease in Patients with Diabetes </p> <p>12. Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients with Diabetes</p> <p>13. Effect of Glucose Management on Coronary Heart Disease Risk in Patients with Diabetes </p> <p>14. Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes</p> <p>15. Effect of Lipid Management on Coronary Heart Disease Risk in Patients with Diabetes </p> <p>16. Effect of Antiplatelet Therapy on Coronary Heart Disease Risk in Patients with Diabetes Mellitus</p> <p>17. Role of Percutaneous Coronary Intervention in Patients with Diabetes </p> <p>18. Role of Coronary Artery Bypass Surgery in Diabetes and Perioperative Glucose Management </p> <p>Section 4 Epidemiology and Management of Acute Coronary Syndromes in Patients with Diabetes </p> <p>19. Epidemiology of Acute Coronary Syndromes in Patients with Diabetes </p> <p>20. Hyperglycemia and Acute Coronary Syndromes: Association with Outcomes and Management </p> <p>21. Antiplatelet and Antithrombotic Therapy in Diabetic Patients with Acute Coronary Syndrome</p> <p>22. Role of Primary Invasive Strategy and Revascularization in Diabetic Patients with Acute Coronary Syndromes </p> <p>Section 5 Heart Failure in Diabetes </p> <p>23. Epidemiology of Heart Failure in Diabetes </p> <p>24. Diabetic Cardiomyopathy: Mediators and Mechanisms</p> <p>25. Prevention of Heart Failure in Patients with Diabetes </p> <p>26. Treatment of Heart Failure in Diabetes: Systolic Dysfunction, Diastolic Dysfunction, and Post-Acute Coronary Syndrome </p> <p>Section 6 Other Diabetes-Related Cardiovascular Considerations </p> <p>27. Peripheral Artery Disease in Diabetes</p> <p>28. Cerebrovascular Disease in Patients with Diabetes </p> <p>29. Cardiac Autonomic Neuropathy </p> <p>30. Disparities in Diabetes Risk, Cardiovascular Consequences, and Care: Women, Ethnic Minorities, and the Elderly </p> <p>31. The Quality Chasm - Diabetes Mellitus</p>
